Offer - Urjas Oil for just ₹ 1 X
Rosupack F is a prescription medicine that is available as a Tablet. Other than this, Rosupack F has some other therapeutic uses, which have been discussed ahead.
The correct dosage of Rosupack F depends on the patient's age, gender, and medical history. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Detailed information has been provided in the dosage section.
The most common side effects of Rosupack F are Nausea or vomiting, Headache, Constipation. Some other side effects of Rosupack F have been listed ahead. Usually, these side effects of Rosupack F go away soon, and do not persist beyond the duration of the treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Rosupack F has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Rosupack F related warnings talks about Rosupack F's effects on the liver, heart and kidney.
Rosupack F is not recommended if you suffer from certain medical conditions as it can have adverse effects. Diabetes are examples of such conditions.
Drug interactions for Rosupack F have been reported in the medical literature. See below for a complete list.
You should also be aware that Rosupack F is not safe while driving, and is not addiction.
Rosupack F is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Adult |
|
Geriatric |
|
Is the use of Rosupack F safe for pregnant women?
Rosupack F may have some side effects during pregnancy. Pregnant women should discontinue the use of Rosupack F, and talk to their doctor, if they notice any discomfort.
Is the use of Rosupack F safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Rosupack F. Immediately discontinue Rosupack F if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Rosupack F on the Kidneys?
Rosupack F rarely harms the kidneys.
What is the effect of Rosupack F on the Liver?
Side effects of Rosupack F rarely affect the liver.
What is the effect of Rosupack F on the Heart?
The heart can be affected by Rosupack F. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Rosupack F should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Rosupack F unless your doctor advises you to do so -
Is this Rosupack F habit forming or addictive?
Forming a habit of Rosupack F has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Rosupack F you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Rosupack F only on doctor's advice.
Is it able to treat mental disorders?
No, the use of Rosupack F in mental disorders is not effective.
Interaction between Food and Rosupack F
Due to a lack of research, nothing can be said about the consequences of taking Rosupack F together with food.
Interaction between Alcohol and Rosupack F
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Rosupack F.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Triglide (fenofibrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 639-640
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 551-552
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Crestor (rosuvastatin calcium)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 636,637
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 646-650